Exchange Bulletin
MediPharm Labs Corp. (LABS) To Trade On Toronto Stock Exchange
Issuer: MediPharm Labs Corp.("MediPharm")
|
Security: |
Common shares (the "Shares") |
|
Symbol: |
LABS |
|
Number of securities issued and outstanding: |
129,810,961 Shares |
|
Number of securities reserved for issuance: |
26,100,659 Shares |
|
Listing category: |
Industrial, Non-Exempt Issuer |
|
Trading currency: |
CDN$ |
|
Listing and posted for trading date: |
July 29, 2019 (at the opening) |
|
Other market(s): |
The Shares have been listed on TSX Venture Exchange ("TSXV") since October 4, 2018, under the symbol "LABS". The Shares will be delisted from TSXV on July 29, 2019, upon commencement of trading on Toronto Stock Exchange. The Shares have also been listed for trading on Frankfurt Stock Exchange under the symbol, "MLZ" and on the OTCQX in the U.S. under the symbol, "MEDIF". |
|
Temporary market maker: |
Altacorp Capital Inc. |
|
Security ownership registration: |
CDS "book-based system" |
|
Investor relations: |
Laura Lepore Vice President, Investor Relations Tel: (705)719-7425 ext. 216 investors@medipharmlabs.com |
|
Incorporation: |
Business Corporations Act (Ontario) |
|
Fiscal year end: |
December 31 |
|
Nature of business: |
MediPharm is a specialized, research-driven cannabis extraction business focused on downstream extraction methodology, distillation, and cannabinoid isolation and purification. MediPharm's mission is to become a leader specialized in providing derivative cannabis products and to drive future cannabis product innovation. |
|
Transfer agent and registrar: |
TSX Trust Company at its principal office in Toronto. |
|
Dividends: |
MediPharm has never paid cash dividends on its Shares and does not anticipate paying any cash dividends for the foreseeable future. |
|
Sponsorship: |
Waived |
|
TSX contact: |
Chris Birkett, Director, Toronto Stock Exchange |
